Gabelli Securities »

Amicus Therapeutics shares owned by Gabelli Securities

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Gabelli Securities from 13F filings

Historical chart of Gabelli Securities investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Gabelli Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Gabelli Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.9M 486k 14.24

More positions owned by Gabelli Securities

Dayforce Equity
Frontier Communications Pare Equity
Chart Industries Equity (GTLS)
Electronic Arts Equity (EA)
Exact Sciences Corp Equity (EXAS)
Avidity Biosciences Equity (RNA)
Cidara Therapeutics Equity (CDTX)
Hologic Equity (HOLX)
Txnm Energy Equity (TXNM)
Gabelli Dividend & Income Tr Exchange Traded (GDV)
Cyberark Software Ltd/israel Equity (CYBR)
Sealed Air Corp Equity (SEE)
Confluent Inc-class A Equity (CFLT)
Gdl Fund Exchange Traded (GDL)
Norfolk Southern Corp Equity (NSC)

View all positions for Gabelli Securities

Top funds holding Amicus Therapeutics

BlackRock
Vanguard Group
Wellington Management Company
State Street Corporation
Millennium Management
Bellevue Group
William Blair Investment Management
Citadel Advisors
Geode Capital Management
Perceptive Advisors
Goldman Sachs Group
UBS Group
Palo Alto Investors
Soleus Capital Management
Soros Fund Management

View all funds holding Amicus Therapeutics